Board Meetings for GKSL
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| GKSL | Gujarat Kidney And Super Speciality Limited | 28 May 2026 | Board Meeting Intimation | GUJARAT KIDNEY AND SUPER SPECIALITY LIMITED has informed the Exchange about Board Meeting to be held on 28-May-2026 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2026 and Other business. | |
| GKSL | Gujarat Kidney And Super Speciality Limited | 28 May 2026 | Financial Results | To consider and approve the audited financial results for the quarter and year ended March 31, 2026 and other matters | |
| GKSL | Gujarat Kidney And Super Speciality Limited | 14 Feb 2026 | Financial Results/Other business matters | The Company has informed the Exchange that a Board meeting to be held on February 13, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on February 14, 2026, To consider and approve the financial results for the period ended December 31, 2025 and other business matters | |
| GKSL | Gujarat Kidney And Super Speciality Limited | 14 Feb 2026 | Board Meeting Intimation | Gujarat Kidney and Super Speciality Limited has informed the Exchange about Board Meeting to be held on 14-Feb-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2025 and Other business. | |
| GKSL | Gujarat Kidney And Super Speciality Limited | 13 Feb 2026 | Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2025 and other business matters | |
| GKSL | Gujarat Kidney And Super Speciality Limited | 13 Feb 2026 | Board Meeting Intimation | Gujarat Kidney and Super Speciality Limited has informed the Exchange about Board Meeting to be held on 13-Feb-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2025 and Other business. |
Showing page 1 of 1 (6 total items)